Combination of purified albumin and aldehyde in optimal ratio with precise mixing inside the applicator of the delivery device allows for full consumption of aldehyde during the polymerisation. As a result, absolutely biocompatible flexible hydrogelis created.

CLINICAL APPLICATIONS:

NE’X Glue® is used as an adjunct to standard methods of repair such as sutures, staples, electrocautery and patches to seal, bond and reinforce tissue. Can be applied alone to fix surgical meshes, reinforce, repair or seal damaged parenchyma as a replacement of ineffective or impractical techniques.

• VASCULAR SURGERY
• CARDIAC SURGERY
• THORACIC SURGERY
• GENERAL SURGERY
• GENITOURINARY SURGERY
• NEUROSURGERY
• ENT SURGERY
• SPINAL SURGERY

4SEAL® Hemostatic Powder absorbs rapidly water from the blood. The dehydration process increases the concentration of red blood cells, platelets, andcoagulation proteins at the bleeding site and thus accelerates the natural blood clotting process.

CLINICAL APPLICATIONS:

4SEAL® Hemostatic Powder is intended for use in surgical procedures or injuries as an adjunct hemostat when control of bleeding from capillary venous, or arteriolar vessel by pressure, ligature and other conventional means is either ineffective or impractical.

4SEAL® Hemostatic Powder can be successfully used in many surgical specialties:

• GENERAL SURGERY
• THORACIC SURGERY
• CARDIOVASCULAR SURGERY
• COLON AND RECTAL SURGERY
• GYNECOLOGY
• NEUROSURGERY
• ORAL AND MAXILLOFACIAL SURGERY
• ORTHOPEDIC SURGERY
• OTOLARYNGOLOGY
• PLASTIC AND MAXILLOFACIAL SURGERY
• UROLOGY

Benefits:

• Biocompatible
• Excellent tensile and suture retention strength
• Does not require special sutures
• Uniform collagen thickness for easier suturing

HANDLING:

• Similar to autologous tissue
• Excellent handling characteristics
• Easily trimmed to desired shape or size

VERCISE GENUS™ R16

• • Rechargeable battery designed to last at least 25 years, with no hard shutoff
  • Zero Volt™ Technology, designed to maintain capacity and resist corrosion during repeated charging cycles
  • MRI conditional
  • Bluetooth connectivity
  • The thinnest DBS stimulator available on the market
  • Cartesia™ 3D enabled

The Vercise™ charging system is completely wireless, and many patients find that charging can be completed in as little as one hour a week.

Key benefits:

• • The rechargeable battery of the Vercise Genus™ R16 offers a 25-year lifespan ​to lessen the risk of repeat surgeries​
  • System upgrade with improved DBS therapy with access to MICC technology and greater programming flexibility.
  • 3x lower risk of patient infection due to no battery replacement operations.
  • Vercise Genus™ has up to 5 times longer run time than competitors.

VERCISE GENUS™ P16

• • The thinnest non-rechargeable battery
  • Contoured for comfort
  • MRI conditional
  • Bluetooth connectivity
  • Cartesia™ 3D enabled

DuraSeal®

The sealant system is indicated for use in brain surgery as an adjunct to standard methods of dura mater closure (suturing). The DuraSeal® system is based on a unique hydrogel technology and allows for minimal time to provide sealing of the dura mater both intraoperatively and for the entire critical healing period.

The resorption period of DuraSeal® is 4-8 weeks and when applied, its volume increases by 50% in all directions.

DuraSeal® Xact

A sealing and anti-spay system is indicated for use in spinal surgeries as an adjunct to standard dura mater healing (suturing) techniques. The DuraSeal® Xact system is a proven method of reliably sealing the dura mater of the spinal cord, as well as an effective anti-inflammatory agent to reduce post-operative peridural fibrosis.

The resorption period of DuraSeal® Xact is 9-12 weeks, and when applied, its volume increases by 12% in all directions.

The Essential Shunt Kit Flat Bottom Design, can be used in (but is not restricted to) situations where skin erosion may be a problem. The Essential Shunt Kit Burr Hole allows to accomodate surgical preferences. Valve and catheters contains barium sulfate. No metal part used in the system eliminating possibility of interference with imaging technology. The implantation is simplified by eliminating connections.

Valve System Unitized

• • Valve
  • 120 cm kink-resistant striped peritoneal catheter unitized
  • 18 cm ventricular catheter with radiopaque markers
  • Stylet
  • Right angle guide

VNS Therapy™ stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures. Uses an implantable generator and lead and can be programmed to fit the needs of each patient. Unlike invasive brain surgeries, VNS Therapy™ involves a short outpatient procedure that usually takes 1 to 2 hours. Treatment is delivered automatically, maximizing adherence for optimal seizure control

SenTiva® is an implantable and programmable pulse generator for the treatment of refractory epilepsy. It provides responsive stimulation to rapid increases in heart rate that may be associated with seizures, allows day-night programming, scheduled programming, and logging of low heart rate and prone position events.

SenTiva® detects and responds to rapid increases in heart rate that may be associated with a seizure

• • In clinical trials, over 60% of seizures treated ended during automatic stimulation.
  • The closer the stimulation to seizure onset, the shorter the seizure duration

Customized control for when your patients need it

• • Tailor programming for specific periods of the day
  • Select which parameters will change, what time the change will occur, and the duration of the change

Safely titrate patients automatically without the need for office visits

• • Program a titration schedule in one office visit
  • Titration changes will be applied while the patient lives their life
  • Simply titrate to the therapeutic range as fast as is tolerated

VNS Therapy™ stimulates the vagus nerve, sending mild electrical pulses to the brain to help prevent seizures. Uses an implantable generator and lead and can be programmed to fit the needs of each patient. Unlike invasive brain surgeries, VNS Therapy™ involves a short outpatient procedure that usually takes 1 to 2 hours. Treatment is delivered automatically, maximizing adherence for optimal seizure control

AspireSR™ – Advancing the treatment of drug-resistant epilepsy

• • Provides the proven efficacy and safety of VNS Therapy
  • Detects and responds to ictal tachycardia in an effort to stop seizures spreading in the brain
  • May terminate seizures by delivering automatic stimulation when a seizure occurs
  • May reduce seizure duration and seizure severity and improve post-ictal recovery
  • Improves quality of life

AspireSR™ detects and responds to rapid increases in heart rate, which may be associated with a seizure

• • In clinical trials, over 60% of seizures treated ended during automatic stimulation.
  • The closer the stimulation to seizure onset, the shorter the seizure duration